In part 3 of this slideshow series, take a look back at the novel drugs and therapeutics approved by the FDA in 2023,1 including treatments for postpartum depression, relapsed or refractory multiple myeloma, and major depressive disorder.
Navigating Women's Health Utilization in a Changing Landscape | AMCP Nexus 2024
October 24th 2024A series of posters presented at AMCP Nexus 2024 highlighted the evolving landscape of women's health, focusing on the use of medications for preterm birth prevention and the adoption of telehealth for prenatal consultations.